PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 23401473-6 2013 Furthermore, silymarin, silybin A, and silybin B (100 microM) significantly inhibited OATP-mediated estradiol-17beta-glucuronide and rosuvastatin uptake into human hepatocytes. Rosuvastatin Calcium 133-145 solute carrier organic anion transporter family member 1A2 Homo sapiens 86-90 21717139-6 2011 Therefore, the present results suggested that the potential drug interaction between danshensu or ursolic acid and rosuvastatin may be mediated by one or more transporters (OATP1B1, OATP 1B3, OATP 1A2, BCRP and NTCP) and/or CYPs. Rosuvastatin Calcium 115-127 solute carrier organic anion transporter family member 1A2 Homo sapiens 192-200 21717139-5 2011 Rosuvastatin is a substrate of drug transporters such as human OATP1B1, OATP 1B3, OATP 1A2, BCRP and NTCP. Rosuvastatin Calcium 0-12 solute carrier organic anion transporter family member 1A2 Homo sapiens 82-90 16697742-7 2006 RESULTS: Multiple OATP family members, including 1B1, 1B3, 2B1, and 1A2, were capable of rosuvastatin transport. Rosuvastatin Calcium 89-101 solute carrier organic anion transporter family member 1A2 Homo sapiens 18-22 21508937-2 2011 In vitro, we found that imatinib is transported by the intestinal uptake carrier organic anion transporting polypeptide (OATP1A2) and that this process is sensitive to pH, rosuvastatin, and genetic variants. Rosuvastatin Calcium 172-184 solute carrier organic anion transporter family member 1A2 Homo sapiens 121-128 29703388-4 2018 Putative mechanisms involve inhibitory effects of GT catechins at the intestinal level on influx transporters OATP1A2 or OATP2B1 for rosuvastatin, on CYP3A for sildenafil and on both CYP3A and the efflux transporter p-glycoprotein for tacrolimus. Rosuvastatin Calcium 133-145 solute carrier organic anion transporter family member 1A2 Homo sapiens 110-117 33037044-0 2020 Calibrating the in vitro-in vivo correlation for OATP mediated drug-drug interactions with rosuvastatin using static and PBPK models. Rosuvastatin Calcium 91-103 solute carrier organic anion transporter family member 1A2 Homo sapiens 49-53 28745105-10 2018 The inhibition of the hOATP1A2-mediated transport of rosuvastatin by these flavonoids was weaker. Rosuvastatin Calcium 53-65 solute carrier organic anion transporter family member 1A2 Homo sapiens 22-30 25858254-9 2016 They also inhibited OATP-mediated uptake of atorvastatin, fluvastatin, and rosuvastatin. Rosuvastatin Calcium 75-87 solute carrier organic anion transporter family member 1A2 Homo sapiens 20-24 27737931-1 2017 Rosuvastatin is a widely prescribed antihyperlipidemic which undergoes limited metabolism, but is an in vitro substrate of multiple transporters [organic anion transporting polypeptide 1B1 (OATP1B1), OATP1B3, OATP1A2, OATP2B1, sodium-taurocholate cotransporting polypeptide, breast cancer resistance protein (BCRP), multidrug resistance protein 2 (MRP2), MRP4, organic anion transporter 3]. Rosuvastatin Calcium 0-12 solute carrier organic anion transporter family member 1A2 Homo sapiens 209-216 25740267-2 2015 To understand the relevance of these in vitro findings, a clinical pharmacokinetic DDI study using rosuvastatin as a BCRP, OATP, and OAT3 probe substrate was conducted. Rosuvastatin Calcium 99-111 solute carrier organic anion transporter family member 1A2 Homo sapiens 123-127 24628404-5 2014 The results showed that OATP-mediated uptake of rosuvastatin, a substrate for OATPs declined substantially in cultured human hepatocytes. Rosuvastatin Calcium 48-60 solute carrier organic anion transporter family member 1A2 Homo sapiens 24-28 25908246-8 2015 OATP1A2-mediated uptake of zolmitriptan, rosuvastatin, and fexofenadine across monolayers increased with increasing OATP1A2 protein expression. Rosuvastatin Calcium 41-53 solute carrier organic anion transporter family member 1A2 Homo sapiens 0-7 25908246-10 2015 A three-compartment model incorporating OATP1A2-mediated influx was used to quantitatively describe the time- and concentration-dependent apical-to-basolateral transcellular transport of rosuvastatin across OATP1A2 expressing the MDCKII monolayer. Rosuvastatin Calcium 187-199 solute carrier organic anion transporter family member 1A2 Homo sapiens 40-47 25908246-10 2015 A three-compartment model incorporating OATP1A2-mediated influx was used to quantitatively describe the time- and concentration-dependent apical-to-basolateral transcellular transport of rosuvastatin across OATP1A2 expressing the MDCKII monolayer. Rosuvastatin Calcium 187-199 solute carrier organic anion transporter family member 1A2 Homo sapiens 207-214 25563901-3 2015 The primary objective of this study was to investigate OATP1A2 transport activity using rosuvastatin as a probe substrate and evaluate competitive inhibition of its transport by beta-blockers. Rosuvastatin Calcium 88-100 solute carrier organic anion transporter family member 1A2 Homo sapiens 55-62 25563901-5 2015 With the exception of carvedilol (IC50 of 3.2 microM), all of the other beta-blockers that were evaluated had a small or insignificant effect on OATP1A2-mediated uptake of rosuvastatin. Rosuvastatin Calcium 172-184 solute carrier organic anion transporter family member 1A2 Homo sapiens 145-152 25563901-9 2015 On the other hand, tricyclic compounds with a short aliphatic amine chain inhibited OATP1A2-mediated rosuvastatin transport. Rosuvastatin Calcium 101-113 solute carrier organic anion transporter family member 1A2 Homo sapiens 84-91